Colfosceril Palmitate

Colfosceril Palmitate is a phospholipid which forms an important constituent of endogenous pulmonary surfactant compounds.

Brands

EXOSURF NEONATAL

Adult Dose

Dose: 5 ml/kg
Single Dose: 5 (5)
Frequency: As recommended.
Route: IV
Instructions: Prophylactic treatment: 1st dose should be given after birth and 2nd and 3rd dose is given 12 and 24 hours later to infants.

Neonatal

Paedriatic

Characteristics

. It is of Synthetic origin. . The Molecular Weight of Colfosceril Palmitate is 734.39.

Contraindications

Colfosceril Palmitate is contraindicated in conditions like Hypersensitivity to any component of product.

Effects

The symptomatic adverse reactions produced by Colfosceril Palmitate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Pulmonary hemorrhage, Obstruction of the endotracheal tube by mucous secretions.

Indications

Colfosceril Palmitate is primarily indicated in conditions like Respiratory distress syndrome.

Interactions

No data regarding the interactions of Colfosceril Palmitate was found.

Interfrence

Risks

Drug should not be given to Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Storage

Store Below 40°C. Freezing is recommended.

Warnings

Continuous monitoring is required to avoid hyperoxaemia (due to rapid improvement in arterial oxygen concentration)

Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.